CCA
ACOR

Canyon Capital Advisors’s Acorda Therapeutics ACOR Stock Holding History

Canyon Capital Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59,699
Closed -$357K – 43
2022
Q3 		$357K Hold
59,699
– – 0.04% 21
2022
Q2 		$556K Buy
59,699
+27,247
+84% +$484K 0.04% 22
2022
Q1 		$1.04M Hold
32,452
– – 0.04% 56
2021
Q4 		$1.55M Buy
32,452
+12,807
+65% +$882K 0.05% 75
2021
Q3 		$1.81M Hold
19,645
– – 0.06% 81
2021
Q2 		$1.87M Buy
19,645
+9,826
+100% +$859K 0.07% 71
2021
Q1 		$956K Buy
+9,819
New +$1.21M 0.04% 75

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $42.8M AUM 0.06% 1-Year Est. Return
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return